Daily non-political popular news in brief.
Oncoproteins double-team and destroy vital tumor-suppressor
02-14-2008 · EurekAlert!Two previously unconnected cancer-promoting proteins team up to ambush a critical tumor suppressor by evicting it from the cell's nucleus and then marking it for death by a protein-shredding mechanism, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the Feb. 10 issue of Nature Cell Biology.
Read more »
Keywords: oncoproteins, double-team, destroy, vital, tumor-suppressor, oncoprotein, double, team, tumor, suppressor
« Previous | Next »
Similar news on "Oncoproteins double-team and destroy vital tumor-suppressor":
- Cancer-resistant mouse discovered
11-27-2007 · EurekAlert!
A mouse resistant to cancer, even highly-aggressive types, has been created by researchers at the University of Kentucky. The breakthrough stems from a discovery by UK College of Medicine professor of radiation medicine Vivek Rangnekar and a team of researchers who found a tumor-suppressor gene called "Par-4" in the prostate.
Similar news · Read more »
- New study reveals for first time how BRCA1 mutations cause breast cancer
12-09-2007 · EurekAlert!
An international team of researchers led by Columbia University Medical Center's Herbert Irving Comprehensive Cancer Center and Sweden's Lund University has, for the first time, revealed how mutations in the BRCA1 gene lead to breast cancer. Findings show that one way BRCA1 mutations cause cancer is by knocking out a powerful tumor suppressor gene known as PTEN.
Similar news · Read more »
- Bits of 'junk' RNA aid master tumor-suppressor gene
08-23-2007 · EurekAlert!
A University of Michigan study reveals that the p53 gene, a key protector mutated in half of all cancers, gets help in its vital job of stifling tumors from a trio of little-known micro RNA genes. Drugs that mimic their benefits could become important tools in cancer therapy someday.
Similar news · Read more »
- Study details regulation of vital tumor suppressor gene p53
09-05-2007 · EurekAlert!
So vital is the p53 tumor suppressor gene in controlling cancer that its dysfunction is linked to more than half of human cancers. Now, a just-published study reveals new levels of subtlety in the body's management of this all-important tumor suppressor gene and the protein it produces. The findings, published in Nature, also outline an important new cycle of gene-regulating modifications that may be widespread in the genome.
Similar news · Read more »
- Gene expression test reveals ER and HER-2 status of breast tumors
02-14-2007 · EurekAlert!
Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online.
Similar news · Read more »
- Scientists and polar explorers brave the elements in support of CryoSat-2
04-19-2007 · European Space Agency (ESA)
It is perhaps an unlikely combination – an international team of scientists stationed in Svalbard, Norway and two polar explorers crossing the North Pole on foot. Both teams, however, are currently part of a common effort to collect vital data on the ground and from the air in support of ESA's ice mission CryoSat-2.
Similar news · Read more »
- Immunosuppressive drugs are a double-edged sword to type 1 diabetics
09-04-2007 · EurekAlert!
Type 1 diabetes occurs when immune cells destroy pancreatic insulin producing beta-cells. It was hoped that islet transplantation would provide a cure for the disease, however, transplant success is short-lived and accompanied by significant side effects. New data indicate that the immunosuppressive drugs used to prevent islet transplant rejection suppress beta-cell regeneration in diabetic mice, raising the possibility that identifying immunosuppressive drugs that do not inhibit beta-cell regeneration might lead to successful regenerative islet transplantation.
Similar news · Read more »
- Novel regulation of the common tumor suppressor PTEN
01-11-2007 · EurekAlert!
PTEN is one of the most commonly mutated tumor suppressor genes. It is an antagonist for many cellular growth, proliferation and survival processes. When mutated or deleted, it causes cancers of the prostate, breast, colon and brain. Researchers led by scientists at Memorial Sloan-Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of PTEN function. The findings from two related studies are published in the Jan. 12 issue of Cell.
Similar news · Read more »
- High-power MRI helps Mayo Clinic surgical team predict outcomes in unusual tumor cases
01-11-2007 · EurekAlert!
A Mayo Clinic surgical team has found that using a 3-Tesla MRI in surgical decision making provides a new level of capability to predict surgical outcomes that improves patient care by minimizing the potential for unsuccessful tumor-removal surgeries. The Mayo Clinic report appears in the December issue of the Journal of Neurosurgery.
Similar news · Read more »
- Targeted tumor therapy: When antagonists do the better job
10-19-2006 · EurekAlert!
Targeted tumor therapy lobs toxic payloads directly into tumors to destroy cancer cells while leaving normal cells unharmed. These missiles, which should unerringly home in on the target and make it implode, consist of lethal payloads guided by small molecules -- known as agonists -- that recognize and then activate specific receptors over-expressed on the surface of tumor cells. A new study shows that it may be better to exploit small molecules that antagonize rather than activate receptors.
Similar news · Read more »
